Variant report
Variant | nsv438057 |
---|---|
Chromosome Location | chr8:58364003-58365122 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1868841 | chr8:58364003-58364004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566399466 | chr8:58364009-58364010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7017841 | chr8:58364039-58364040 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs184699633 | chr8:58364075-58364076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs56092901 | chr8:58364097-58364098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188544134 | chr8:58364204-58364205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75232794 | chr8:58364207-58364208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111903619 | chr8:58364249-58364250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10957001 | chr8:58364300-58364301 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs79389511 | chr8:58364314-58364315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552515553 | chr8:58364351-58364352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572486704 | chr8:58364385-58364386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545003330 | chr8:58364397-58364398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368352243 | chr8:58364407-58364408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565181815 | chr8:58364408-58364409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541315338 | chr8:58364431-58364432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546499263 | chr8:58364495-58364496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575388905 | chr8:58364506-58364507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544353717 | chr8:58364544-58364545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs193075673 | chr8:58364557-58364558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2325743 | chr8:58364585-58364586 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs375182432 | chr8:58364594-58364595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75151772 | chr8:58364642-58364643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184885150 | chr8:58364650-58364651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369083026 | chr8:58364652-58364653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189930688 | chr8:58364655-58364656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576529511 | chr8:58364673-58364674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149403665 | chr8:58364703-58364704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561582262 | chr8:58364725-58364726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181139905 | chr8:58364743-58364744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537258357 | chr8:58364784-58364785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144808887 | chr8:58364822-58364823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2325744 | chr8:58364888-58364889 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs535973241 | chr8:58364970-58364971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374829630 | chr8:58365024-58365025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs55662716 | chr8:58365079-58365080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551226836 | chr8:58365107-58365108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572796953 | chr8:58365110-58365111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538618929 | chr8:58365112-58365113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7817044 | chr8:58365122-58365123 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:58353000-58364400 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr8:58362200-58368000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr8:58362800-58364400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr8:58363200-58370000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr8:58364000-58365000 | Weak transcription | Fetal Lung | lung |